We are live on ! Find out more
CC

Chicago Capital Portfolio holdings

AUM $4.15B
1-Year Est. Return 31.09%
This Fund
S&P 500
This Quarter Est. Return
+4.82%
1 Year Est. Return
+31.09%
3 Year Est. Return
+117.08%
5 Year Est. Return
+137.61%
10 Year Est. Return
AUM
$3.77B
AUM Growth
+$170M
Cap. Flow
+$54.5M
Cap. Flow %
1.45%
Top 10 Hldgs %
33.11%
Holding
341
New
28
Increased
122
Reduced
88
Closed
23

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$16.7M
2
VRT icon
Vertiv
VRT
+$11.2M
3
PRCT icon
Procept Biorobotics
PRCT
+$9.99M
4
LLY icon
Eli Lilly
LLY
+$9.7M
5
MSFT icon
Microsoft
MSFT
+$5.89M

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$5.86M
2
AAPL icon
Apple
AAPL
+$3.39M
3
ALIT icon
Alight
ALIT
+$3.37M
4
IDXX icon
Idexx Laboratories
IDXX
+$3.24M
5
ANET icon
Arista Networks
ANET
+$1.76M

Sector Composition

Rank Sector Weight
1 Technology 29.34%
2 Healthcare 17.25%
3 Communication Services 14.23%
4 Financials 12.77%
5 Consumer Discretionary 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PWR icon
51
Quanta Services
PWR
$100B
$15.7M 0.42%
49,682
+785
+2% +$253K
CDNS icon
52
Cadence Design Systems
CDNS
$93.6B
$14.7M 0.39%
48,776
+1,364
+3% +$397K
DELL icon
53
Dell
DELL
$262B
$14M 0.37%
121,374
-92
-0.1% -$11.5K
AXON
54
Axon Enterprise
AXON
$42.5B
$13.9M 0.37%
23,358
+1,775
+8% +$965K
JPM icon
55
JPMorgan Chase
JPM
$935B
$13.4M 0.35%
55,724
-3,806
-6% -$886K
ZBRA icon
56
Zebra Technologies
ZBRA
$14B
$12.6M 0.33%
32,643
-10
-0% -$3.87K
VRT icon
57
Vertiv
VRT
$93B
$12.5M 0.33%
110,286
+94,195
+585% +$11.2M
LIN icon
58
Linde
LIN
$221B
$12M 0.32%
28,565
-780
-3% -$355K
IVV icon
59
iShares Core S&P 500 ETF
IVV
$878B
$11.3M 0.3%
19,279
+55
+0.3% +$32.6K
ORCL icon
60
Oracle
ORCL
$374B
$11M 0.29%
66,147
+4,456
+7% +$792K
PLTR icon
61
Palantir
PLTR
$295B
$11M 0.29%
145,155
+1,953
+1% +$114K
IRM icon
62
Iron Mountain
IRM
$36.4B
$10.8M 0.29%
103,077
+24
+0% +$2.82K
OABI icon
63
OmniAb
OABI
$287M
$10.5M 0.28%
2,975,451
-187,104
-6% -$740K
FAST icon
64
Fastenal
FAST
$54.7B
$10.5M 0.28%
291,960
-5,352
-2% -$209K
SPGI icon
65
S&P Global
SPGI
$121B
$10.3M 0.27%
20,668
-206
-1% -$105K
VST icon
66
Vistra
VST
$50B
$9.72M 0.26%
70,481
-682
-1% -$94.7K
ABBV icon
67
AbbVie
ABBV
$443B
$9.42M 0.25%
53,003
+307
+0.6% +$56.4K
MCK icon
68
McKesson
MCK
$100B
$9.02M 0.24%
15,825
+3
+0% +$1.68K
AVGO icon
69
Broadcom
AVGO
$1.85T
$8.68M 0.23%
37,441
-581
-2% -$107K
AMD icon
70
Advanced Micro Devices
AMD
$776B
$8.58M 0.23%
71,051
+998
+1% +$144K
JNJ icon
71
Johnson & Johnson
JNJ
$618B
$8.15M 0.22%
56,339
-3,396
-6% -$526K
AIR icon
72
AAR Corp
AIR
$5.59B
$7.84M 0.21%
127,951
TSLA icon
73
Tesla
TSLA
$1.23T
$7.52M 0.2%
18,609
+621
+3% +$200K
PEP icon
74
PepsiCo
PEP
$190B
$7.3M 0.19%
48,020
-602
-1% -$98.6K
VOO icon
75
Vanguard S&P 500 ETF
VOO
$979B
$7.06M 0.19%
13,110
+162
+1% +$87.7K

Similar funds

Chicago Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Chicago Capital held 341 positions worth $3.77B, up 4.7% from $3.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Chicago Capital's Q4 2024 filing shows 28 new, 122 increased, 88 reduced and 23 closed positions. Its largest new stake was lululemon athletica: 4,106 shares worth $1.57M. The largest sale was Edwards Lifesciences, an estimated $5.86M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Communication Services.

  • Chicago Capital's largest Q4 2024 buy was lululemon athletica: 4,106 shares worth $1.57M.
  • Chicago Capital added most to Boston Scientific in Q4 2024, an estimated $16.7M increase.
  • Chicago Capital's biggest Q4 2024 reduction was Edwards Lifesciences, cutting an estimated $5.86M.
  • Chicago Capital fully exited Alight in Q4 2024, selling an estimated $3.37M.
  • Chicago Capital's ten largest holdings make up 33% of its $3.77B portfolio in Q4 2024.
  • Chicago Capital opened 28 new positions and closed 23 in Q4 2024.
  • Chicago Capital's portfolio value rose 4.7% quarter-over-quarter to $3.77B.

Based on Chicago Capital's 13F filing for Q4 2024, filed 24 Jan 2025.